We are thrilled to announce that Constructive Bio has successfully raised $75 million in a recent funding round, marking a significant milestone in our journey towards revolutionizing the field of synthetic biology. Founded as a spin-out from the esteemed laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge, Constructive Bio is at the forefront of genetic engineering. Our innovative platform empowers us to skillfully write precise DNA sequences, enabling us to manipulate biological systems and create molecules that have never existed before. This groundbreaking capability allows us to fundamentally reprogram the genetic code, opening doors to a plethora of possibilities in biosynthesis. The funds raised will be pivotal in accelerating our research and development efforts, particularly in creating new classes of enzymes, pharmaceuticals, and biomaterials that can address pressing challenges in healthcare and environmental sustainability. As we embark on this exciting chapter, we are also on the lookout for passionate individuals to join our team and be a part of this transformative journey. Together, we can harness the power of biology to create a better, more sustainable future. If you are interested in contributing to our mission or learning more about our work, we invite you to reach out and connect with us. Stay tuned for more updates as we continue to push the boundaries of what is possible in the realm of constructively written DNA!








